Inhibition of host cell signal transduction by Leishmania: Observations relevant to the selective impairment of IL-12 responses

Current Opinion in Microbiology

Volumn 2, Issue 4, 1999, Pages 438-443

  McDowell, Mary Ann ^a   Sacks, David L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12;

CELLULAR IMMUNITY; HOST CELL; LEISHMANIA; LIGATION; MACROPHAGE; PHAGOCYTE; PHOSPHORYLATION; PROTOZOAL INFECTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033178799     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(99)80077-0     Document Type: Review

References (67)

1. Buchmuller-Rouiller Y, Mauel J: Impairment of the oxidative metabolism of mouse peritoneal macrophages by intracellular Leishmania spp. Infect Immun 1987, 55:587-593.
2. Olivier M, Brownsey RW, Reiner NE: Defective stimulus-response coupling in human monocytes infected with Leishmania donovani is associated with altered activation and translocation of protein kinase C. Proc Natl Acad Sci USA 1992, 89:7481 -7485.
3. Green SJ, Crawford RM, Hockmeyer JT, Meltzer MS, Nacy CA: Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J Immunol 1990, 145:4290-4297.
4. Murray HW, Masur H, Keithly JS: Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity. J Immunol 1982, 129:344-350.
5. Belosevic M, Finbloom DS, Van Der Meide PH, Slayter MV, Nacy CA: Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J Immunol 1989, 143:266-274.
6. Reiner NE, Ng W, Ma T, McMaster WR: Kinetics of gamma interferon binding and induction of major histocompatibility complex class II mRNA in Leishmania-infected macrophages. Proc Natl Acad Sci USA 1988, 85:4330-4334.
7. Reiner NE, Ng W, McMaster WR: Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. J Immunol 1987, 138: 1926-1932.
8. Kaye PM, Rogers NJ, Curry AJ, Scott JC: Deficient expression of costimulatory molecules on Leishmania-infected macrophages. Eur J Immunol 1994, 24:2850-2854.
9. Prina E, Antoine JC, Wiederanders B, Kirschke H: Localization and activity of various lysosomal proteases in Leishmania amazonensis-infected macrophages. Infect Immun 1990, 58:1730-1737.
10. Reiner NE: Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani. J Immunol 1987, 138:1919-1925.
11. Carrera L, Gazzinelli RT, Badolato R, Hieny S, Muller W, Kuhn R, Sacks DL: Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med 1996, 183:515-526.
12. Chakkalath HR, Titus RG: Leishmania mayor-parasitized macrophages augment Th2-type T cell activation. J Immunol 1994, 153:4378-4387.
13. Cillari E, Dieli M, Maltese E, Milano S, Salerno A, Liew FY: Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-gamma. J Immunol 1989, 143:2001-2005.
14. Moore KJ, Matlashewski G: Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J Immunol 1994, 152:2930-2937.
15. + T cells during initiation of infection. J Exp Med 1994, 179:447-456.
16. Belkaid Y, Butcher B, Sacks DL: Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: Selective impairment of IL-12 induction in Leishmania-infected cells. Eur J Immunol 1998, 28:1389-1400. For the first time, IL-12 inhibition at the single cell level is investigated. Using two color FACS analysis for intracellular cytokine expression and parasite infection, this study illustrates that IL-12 induction in Leishmania infected inflammatory macrophages is selectively suppressed in response to interferon-γ and lipopolysaccharide stimulation.
17. Ma X, Reiman H, Gri G, Trinchieri G: Positive and negative regulation of interleukin-12 gene expression. Eur Cytokine Netw 1998, 9(suppl):53-64.
18. Mattner F, Magram J, Ferrante J, Launois P, Di Padova K, Behin R, Gately MK, Louis JA, Alber G: Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol 1996, 26:1553-1559.
19. Sypek JP, Chung CL, Mayor SE, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG: Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 1993, 177:1797-1802.
20. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK: Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 1993, 177:1505-1509.
21. Cooper AM, Roberts AD, Rhoades ER, Callahan JE, Getzy DM, Orme IM: The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 1995, 84:423-432.
22. Song F, Matsuzaki G, Mitsuyama M, Nomoto K: Differential effects of viable and killed bacteria on IL-12 expression of macrophages. J Immunol 1996, 156:2979-2984
23. Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, Caspar P, Trinchieri G, Sher A: Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol 1994, 153:2533-2543.
24. Aliberti JC, Cardoso MA, Martins GA, Gazzinelli RT, Vieira LO, Silva JS: Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect Immun 1996, 64:1961-1967.
25. Probst P, Skeiky YA, Steeves M, Gervassi A, Grabstein KH, Reed SG: A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells. Eur J Immunol 1997, 27:2634-2642.
26. Skeiky YA, Kennedy M, Kaufman D, Borges MM, Guderian JA, Scholler JK, Ovendale PJ, Picha KS, Morrissey PJ, Grabstein KH et al.: LeIF: A recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile. J Immunol 1998, 161:6171-6179.
27. Piedrafita D, Proudfoot L, Nikolaev AV, Xu D, Sands W, Feng GJ, Thomas E, Brewer J, Ferguson MA, Alexander J, Liew FY: Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans. Eur J Immunol 1999, 29:235-244. Currently the only study that investigates the mechanisms controlling the transcriptional inhibition of IL-12 by Leishmania; NFκB activation and DNA binding ability is not affected by Leishmania infection in a murine macrophage cell line. In addition, a leishmanial product, phosphoglycan, can induce the IL-12 inhibition in the absence of infection.
28. Sartori A, Oliveira MA, Scott P, Trinchieri G: Metacyclogenesis modulates the ability of Leishmania promastigotes to induce IL-12 production in human mononuclear cells. J Immunol 1997, 159:2849-2857.
29. Weinheber N, Wolfram M, Harbecke D, Aebischer T: Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production. Eur J Immunol 1998, 28:2467-2477. This work suggests that L. amazonensis employs a post-transcriptional mechanism to inhibit IL-12 secretion by macrophages.
30. Ma X, Aste-Amezaga M, Trinchieri G: Regulation of interleukin-12 production. Ann N Y Acad Sci 1996, 795:13-25.
31. Murphy TL, Cleveland MG, Kulesza P, Magram J, Murphy KM: Regulation of interleukin 12 p40 expression through an NF-kappa B half-site. Mol Cell Biol 1995, 15:5258-5267.
32. Ma X, Neurath M, Gri G, Trinchieri G: Identification and characterization of a novel ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter. J Biol Chem 1997, 272:10389-10395.
33. Gri G, Savio D, Trinchieri G, Ma X: Synergistic regulation of the human interleukin-12 p40 promoter by NFkappaB and Ets transcription factors in Epstein-Barr-virus-transformed B cells and macrophages. J Biol Chem 1998, 273:6431-6438.
34. Yoshimoto T, Nagase H, Ishida T, Inoue J, Nariuchi H: Induction of interleukin-12 p40 transcript by CD40 ligation via activation of nuclear factor-kappaB. Eur J Immunol 1997, 27:3461-3470.
35. Plevy SE, Gemberling JH, Hsu S, Dorner AJ, Smale ST: Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: Evidence of functional synergy between C/EBP and Rel proteins. Mol Cell Biol 1997, 17:4572-4588.
36. Giese NA, Gabriele L, Doherty TM, Klinman DM, Tadesse-Heath L, Contursi C, Epstein SL, Morse HC 3rd: Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression. J Exp Med 1997, 186:1535-1546.
37. Wu CY, Maeda H, Contursi C, Ozato K, Seder RA: Differential requirement of IFN consensus sequence binding protein for the production of IL-12 and induction of Th1-type cells in response to IFN-gamma. J Immunol 1999, 162:807-812.
38. Scharton-Kersten T, Contursi C, Masumi A, Sher A, Ozato K: Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction. J Exp Med 1997, 186:1523-1534.
39. Descoteaux A, Turco SJ: The lipophosphoglycan of Leishmania and macrophage protein kinase C. Parasitol Today 1993, 9:468-471.
40. Reiner NE: Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol Today 1994, 15:374-381.
41. McNeely TB, Turco SJ: Inhibition of protein kinase C activity by the Leishmania donovani lipophosphoglycan. Biochem Biophys Res Commun 1987, 148:653-657.
42. Giorgione JR, Turco SJ, Epand RM: Transbilayer inhibition of protein kinase C by the lipophosphoglycan from Leishmania donovani. Proc Natl Acad Sci USA 1996, 93:11634-11639.
43. Karras JG, Wang Z, Huo L, Frank DA, Rothstein TL: Induction of STAT protein signaling through the CD40 receptor in B lymphocytes: Distinct STAT activation following surface Ig and CD40 receptor engagement. J Immunol 1997, 159:4350-4355.
44. Hanissian SH, Geha RS: Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 1997, 6:379-387.
45. Haque SJ, Williams BR: Signal transduction in the interferon system. Semin Oncol 1998, 25:14-22.
46. Kanno Y, Kozak CA, Schindler C, Driggers PH, Ennist DL, Gleason SL, Darnell JE Jr, Ozato K: The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds. Mol Cell Biol 1993, 13:3951-3963.
47. Nandan D, Reiner NE: Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: Selective inhibition of signaling through Janus kinases and Stat1. Infect Immun 1995, 63:4495-4500.
48. May MJ, Ghosh S: Signal transduction through NF-kappa B. Immunol Today 1998, 19:80-88.
49. Sutterwala FS, Noel GJ, Clynes R, Mosser DM: Selective suppression of interleukin-12 induction after macrophage receptor ligation. J Exp Med 1997, 185:1977-1985.
50. Marth T, Kelsall BL: Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med 1997, 185:1987-1995.
51. Berger S, Chandra R, Ballo H, Hildenbrand R, Stutte HJ: Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes. Eur J Immunol 1997, 27:2994-3000.
52. Mosser DM, Edelson PJ: Activation of the alternative complement pathway by Leishmania promastigotes: Parasite lysis and attachment to macrophages. J Immunol 1984, 132:1501-1505.
53. Mosser DM, Edelson PJ: The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes. J Immunol 1985, 135:2785-2789.
54. Dominguez M, Torano A: Immune adherence-mediated opsonophagocytosis: The mechanism of Leishmania infection. J Exp Med 1999, 189:25-35.
55. Mosser DM, Rosenthal LA: Leishmania-macrophage interactions: Multiple receptors, multiple ligands and diverse cellular responses. Semin Cell Biol 1993, 4:315-322.
56. Da Silva RP, Hall BF, Joiner KA, Sacks DL: CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J Immunol 1989, 143:617-622.
57. Guy RA, Belosevic M: Comparison of receptors required for entry of Leishmania major amastigotes into macrophages. Infect Immun 1993, 61:1553-1558.
58. Talamas-Rohana P, Wright SD, Lennartz MR, Russell DG: Lipophosphoglycan from Leishmania mexicana promastigotes binds to members of the CR3, p150,95 and LFA-1 family of leukocyte integrins. J Immunol 1990, 144:4817-4824.
59. Blackwell JM, Ezekowitz RA, Roberts MB, Channon JY, Sim RB, Gordon S: Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J Exp Med 1985, 162:324-331.
60. Wilson ME, Pearson RD: Roles of CR3 and mannose receptors in the attachment and ingestion of Leishmania donovani by human mononuclear phagocytes. Infect Immun 1988, 56:363-369.
61. Chehimi J, Starr SE, Frank I, D'Andrea A, Ma X, MacGregor RR, Sennelier J, Trinchieri G: Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 1994, 179:1361-1366.
62. Chougnet C, Wynn TA, Clerici M, Landay AL, Kessler HA, Rusnak J, Melcher GP, Sher A, Shearer GM: Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J Infect Dis 1996, 174:46-53.
63. Karp CL, Wysocka M, Wahl LM, Ahearn JM, Cuomo PJ, Sherry B, Trinchieri G, Griffin DE: Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996, 273:228-231.
64. David M, Chen HE, Goelz S, Larner AC, Neel BG: Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 1995, 15:7050-7058.
65. You M, Yu DH, Feng GS: Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol Cell Biol 1999, 19:2416-2424.
66. Starr R, Hilton DJ: Negative regulation of the JAK/STAT pathway [In Process Citation]. Bioessays 1999, 21:47-52.
67. Gottlieb M, Dwyer DM: Leishmania donovani: Surface membrane acid phosphatase activity of promastigotes. Exp Parasitol 1981, 52:117-128.